Search Results - "Geroyianni, A"

Chemotherapy-induced neutropenia as a prognostic factor in patients with advanced non-small cell lung cancer treated with front-line docetaxel–gemcitabine chemotherapy by Pallis, A.G, Agelaki, S, Kakolyris, S, Kotsakis, A, Kalykaki, A, Vardakis, N, Papakotoulas, P, Agelidou, A, Geroyianni, A, Agelidou, M, Hatzidaki, D, Mavroudis, D, Georgoulias, V

“…Summary Background Front-line docetaxel–gemcitabine (DG) combination represents an alternative to platinum-based chemotherapy in patients with advanced NSCLC…”
Get full text

Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study by Boukovinas, I, Souglakos, J, Hatzidaki, D, Kakolyris, S, Ziras, N, Vamvakas, L, Polyzos, A, Geroyianni, A, Agelidou, A, Agelaki, S, Kalbakis, K, Kotsakis, A, Mavroudis, D, Georgoulias, V

“…Summary Background The docetaxel/gemcitabine (DG) combination is an active and well-tolerated regimen against non-small cell lung cancer (NSCLC). A phase II…”
Get full text

Cisplatin plus etoposide chemotherapy followed by thoracic irradiation and paclitaxel plus cisplatin consolidation therapy for patients with limited stage small cell lung carcinoma by Kakolyris, S., Agelidou, A., Androulakis, N., Tsaroucha, E., Kouroussis, Ch, Agelidou, M., Karvounis, N., Veslemes, M., Christophylakis, Ch, Argyraki, A., Geroyianni, A., Georgoulias, V.

“…To evaluate the efficacy and tolerance of a cisplatin plus etoposide regimen followed by thoracic radiotherapy (TRT) and paclitaxel plus cisplatin…”
Get full text

Vinorelbine and cisplatin combination in pretreated patients with advanced non-small cell lung cancer pretreated with a taxane-based regimen: A multicenter phase II study by Makrantonakis, P., Ziotopoulos, P., Agelidou, A., Polyzos, A., Ziras, A., Chandrinos, V., Vossos, A., Kalykaki, A., Androulakis, N., Geroyianni, A., Georgoulias, V.

“…To assess the efficacy and tolerance of the vinorelbine/cisplatin combination in non-small cell lung cancer patients pre-treated with a taxane-based regimen…”
Get full text

Salvage treatment with paclitaxel and gemcitabine for patients with non-small-cell lung cancer after cisplatin- or docetaxel-based chemotherapy: A multicenter phase II study by Androulakis, N., Kouroussis, C., Kakolyris, S., Tzannes, S., Papadakis, E., Papadimitriou, C., Geroyianni, A., Georgopoulou, T., Dimopoulou, I., Souglakos, J., Kotsakis, A., Vardakis, N., Hatzidaki, D., Georgoulias, V.

“…Background: To evaluate the tolerance and efficacy of the combination of paclitaxel and gemcitabine as salvage treatment in patients with advanced…”
Get full text

The sequential administration of cisplatin-etoposide followed by topotecan in patients with extensive stage small cell lung cancer (SCLC). A multicenter phase II study by Mavroudis, D., Agelaki, S., Palamidas, Ph, Kouroussis, Ch, Harpidou, A., Toubis, M., Geroyianni, A., Samonis, G., Georgoulias, V.

Get full text